DV
Dividend Vision

HRTS — Tema Cardiovascular and Metabolic ETF

Tema Cardiovascular and Metabolic ETF (HRTS)

HRTS pays a 1.30% distribution rate, on a 0.75% expense ratio. Its Distribution Safety Score™ is 50 (Caution). Total return is 43.7% over the past 2.7 years, 33.5 points behind SPY at 77.2%. Its deepest 1-year drawdown was 11.0%.

Tema Cardiovascular and Metabolic ETF is an equity fund that invests at least eighty percent of its assets in publicly listed companies deriving at least half their revenues from GLP-1 products, cardiovascular treatments, or metabolic disease therapies; the fund typically holds between fifteen and one hundred companies and is non-diversified. It carries an expense ratio of 0.75% and distributes at a modest rate. The fund appeals to investors seeking exposure to the cardiovascular and metabolic health treatment sectors.

HRTS key facts

Distribution Safety Score™
50 · Caution
Issuer
Tema ETFs
Asset type
ETF
Asset class
Equity
Inception date
11/20/2023
Expense ratio
0.75%
Distribution rate
1.30%
Trailing yield
1.27%
Last close
$37.19
AUM
$53,585,298
Average volume
4006.0
Last dividend
$0.4730
Ex-dividend date
12/10/2025
Payment date
12/11/2025
P/E ratio
25.4482